Filing Details
- Accession Number:
- 0000784199-21-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-19 16:28:35
- Reporting Period:
- 2021-02-17
- Accepted Time:
- 2021-02-19 16:28:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 784199 | Cryolife Inc | CRY | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1742150 | B Dennis Maier | 1655 Roberts Blvd, Nw Kennesaw GA 30144 | Vice President, Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-17 | 6,630 | $21.55 | 23,211 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-17 | 6,630 | $24.73 | 16,581 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-17 | 567 | $24.64 | 16,014 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-02-17 | 3,902 | $0.00 | 19,916 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2021-02-17 | 6,630 | $21.55 | 6,630 | $21.55 |
| Common Stock | Stock Options (Right to Buy) | Acquisiton | 2021-02-17 | 11,017 | $0.00 | 11,017 | $24.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-03-12 | 2025-03-12 | No | 4 | M | Direct |
| 11,017 | 2022-02-17 | 2028-02-17 | No | 4 | A | Direct |
Footnotes
- Reflects the price of $24.7335 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price
- Reflects the price of $24.6436 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price
- Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company.
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 3/12/2019
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date.
Billionaire Hedge Funds
